Brind.

Scientists Discuss AI's Role and Limits in Drug Discovery in Shanghai

1 report, 1 independent Updated Mon 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

A forum was held in Shanghai on November 9, 2026, to discuss the potential of artificial intelligence in drug discovery. Three leading scientists—Michael Levitt, Daniela Rhodes, and Pascal Mayer—participated, offering contrasting views on how the technology could reshape scientific research. Michael Levitt cautioned that AI predictions can be a 'black box,' noting that biology itself remains complex.

From en.people.cn

Why it matters

Some supportBrind's analysis of the reports

The discussion centered on AI's ability to identify correct biological targets and predict how drugs will behave in the human body. The forum highlighted the critical role of AI in advancing pharmaceutical innovation, which is a high-value sector.

From en.people.cn

Who's involved

  • ShanghaiLocation where the AI research forum was held.
  • Michael LevittBiophysicist who discussed AI's limitations in drug discovery.
  • Daniela RhodesStructural and molecular biologist who discussed AI's promise in drug discovery.

Possible ripples

Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped